AstraZeneca to Pay $5.5M to Settle FCPA Claims

, Corporate Counsel

   | 0 Comments

AstraZeneca agreed Tuesday to pay $5.5 million in penalties and interest to settle claims that it violated the Foreign Corrupt Practices Act through improper payments to health care providers in China and Russia.

This premium content is reserved for Global Lawyer News subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202766464431

Thank you!

This article's comments will be reviewed.